研究基于正念的认知疗法(MBCT)对复发性抑郁症的治疗效果和治疗方式:PREVENT 试验中的中介分析

Jesus Montero-Marin, Verena Hinze, Shannon Maloney, Anne Maj van der Velden, Rachel Hayes, Edward R. Watkins, Sarah Byford, Tim Dalgleish, Willem Kuyken
{"title":"研究基于正念的认知疗法(MBCT)对复发性抑郁症的治疗效果和治疗方式:PREVENT 试验中的中介分析","authors":"Jesus Montero-Marin, Verena Hinze, Shannon Maloney, Anne Maj van der Velden, Rachel Hayes, Edward R. Watkins, Sarah Byford, Tim Dalgleish, Willem Kuyken","doi":"10.1192/bjp.2024.178","DOIUrl":null,"url":null,"abstract":"<span>Background</span><p>Personalised management of recurrent depression, considering individual patient characteristics, is crucial.</p><span>Aims</span><p>This study evaluates the potentially different mediating role of mindfulness skills in managing recurrent depression using mindfulness-based cognitive therapy (MBCT) among people with varying depression severity.</p><span>Method</span><p>Data from the Prevention of Depressive Relapse or Recurrence (PREVENT) trial, comparing MBCT (with antidepressant medication (ADM) tapering support, MBCT-tapering support) versus maintenance-ADM, were used. The study included pre, post, 9-, 12-, 18- and 24-month follow-ups. Adults with ≥3 previous major depressive episodes, in full/partial remission (below threshold for a current episode), on ADM, were assessed for eligibility in primary care practices in the UK. People were randomised (1:1) to MBCT-tapering support or maintenance-ADM. We used the Beck Depression Inventory-II to evaluate depressive symptom changes over the six time points. Pre-post treatment, we employed the Five Facets of Mindfulness Questionnaire to gauge mindfulness skills. Baseline symptom and history variables were used to identify individuals with varying severity profiles. We conducted Latent Profile Moderated-Mediation Growth Mixture Models.</p><span>Results</span><p>A total of 424 people (mean (s.d.) age = 49.44 (12.31) years; with 325 (76.7%) self-identified as female) were included. A mediating effect of mindfulness skills, between trial arm allocation and the linear rate of depressive symptoms change over 24 months, moderated by depression severity, was observed (moderated-mediation index = −0.27, 95% CI = −0.66, −0.03). Conditional indirect effects were −0.42 (95% CI = −0.78, −0.18) for higher severity (expected mean BDI-II reduction = 10 points), and −0.15 (95% CI = −0.35, −0.02) for lower severity (expected mean BDI-II reduction = 3.5 points).</p><span>Conclusions</span><p>Mindfulness skills constitute a unique mechanism driving change in MBCT (versus maintenance-ADM). Individuals with higher depression severity may benefit most from MBCT-tapering support for residual symptoms. It is unclear if these effects apply to those with a current depressive episode. Future research should investigate individuals who are not on medication. This study provides preliminary evidence for personalised management of recurrent depression.</p><span>Trial Registration:</span><p>ISRCTN26666654.</p>","PeriodicalId":22495,"journal":{"name":"The British Journal of Psychiatry","volume":"9 7 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-11-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Examining what works for whom and how in mindfulness-based cognitive therapy (MBCT) for recurrent depression: moderated-mediation analysis in the PREVENT trial\",\"authors\":\"Jesus Montero-Marin, Verena Hinze, Shannon Maloney, Anne Maj van der Velden, Rachel Hayes, Edward R. Watkins, Sarah Byford, Tim Dalgleish, Willem Kuyken\",\"doi\":\"10.1192/bjp.2024.178\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<span>Background</span><p>Personalised management of recurrent depression, considering individual patient characteristics, is crucial.</p><span>Aims</span><p>This study evaluates the potentially different mediating role of mindfulness skills in managing recurrent depression using mindfulness-based cognitive therapy (MBCT) among people with varying depression severity.</p><span>Method</span><p>Data from the Prevention of Depressive Relapse or Recurrence (PREVENT) trial, comparing MBCT (with antidepressant medication (ADM) tapering support, MBCT-tapering support) versus maintenance-ADM, were used. The study included pre, post, 9-, 12-, 18- and 24-month follow-ups. Adults with ≥3 previous major depressive episodes, in full/partial remission (below threshold for a current episode), on ADM, were assessed for eligibility in primary care practices in the UK. People were randomised (1:1) to MBCT-tapering support or maintenance-ADM. We used the Beck Depression Inventory-II to evaluate depressive symptom changes over the six time points. Pre-post treatment, we employed the Five Facets of Mindfulness Questionnaire to gauge mindfulness skills. Baseline symptom and history variables were used to identify individuals with varying severity profiles. We conducted Latent Profile Moderated-Mediation Growth Mixture Models.</p><span>Results</span><p>A total of 424 people (mean (s.d.) age = 49.44 (12.31) years; with 325 (76.7%) self-identified as female) were included. A mediating effect of mindfulness skills, between trial arm allocation and the linear rate of depressive symptoms change over 24 months, moderated by depression severity, was observed (moderated-mediation index = −0.27, 95% CI = −0.66, −0.03). Conditional indirect effects were −0.42 (95% CI = −0.78, −0.18) for higher severity (expected mean BDI-II reduction = 10 points), and −0.15 (95% CI = −0.35, −0.02) for lower severity (expected mean BDI-II reduction = 3.5 points).</p><span>Conclusions</span><p>Mindfulness skills constitute a unique mechanism driving change in MBCT (versus maintenance-ADM). Individuals with higher depression severity may benefit most from MBCT-tapering support for residual symptoms. It is unclear if these effects apply to those with a current depressive episode. Future research should investigate individuals who are not on medication. This study provides preliminary evidence for personalised management of recurrent depression.</p><span>Trial Registration:</span><p>ISRCTN26666654.</p>\",\"PeriodicalId\":22495,\"journal\":{\"name\":\"The British Journal of Psychiatry\",\"volume\":\"9 7 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-11-08\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"The British Journal of Psychiatry\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1192/bjp.2024.178\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"The British Journal of Psychiatry","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1192/bjp.2024.178","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

背景考虑到患者的个体特征,对复发性抑郁症进行个性化管理至关重要。目的本研究评估了正念技能在使用正念认知疗法(MBCT)管理不同严重程度抑郁症患者的复发性抑郁症过程中可能发挥的不同中介作用。方法使用了 "预防抑郁症复发或复发(PREVENT)"试验中的数据,该试验比较了 MBCT(含抗抑郁药物(ADM)减量支持,MBCT-减量支持)与维持-ADM。研究包括前期、后期、9 个月、12 个月、18 个月和 24 个月的随访。在英国的初级医疗实践中,对既往有≥3次重度抑郁发作、完全/部分缓解(低于当前发作的阈值)、接受ADM治疗的成人进行了资格评估。受试者被随机分配(1:1)接受MBCT治疗支持或ADM维持治疗。我们使用贝克抑郁量表 II 评估抑郁症状在六个时间点上的变化。在治疗前和治疗后,我们使用正念五方面问卷来评估正念技能。基线症状和病史变量用于识别不同严重程度的个体。我们建立了潜特征中介增长混合模型。结果 共纳入 424 人(平均(s.d. )年龄 = 49.44 (12.31) 岁;325 人(76.7%)自认为女性)。在试验臂分配与抑郁症状24个月线性变化率之间,观察到正念技能的中介效应(中介指数 = -0.27,95% CI = -0.66,-0.03),抑郁症严重程度起调节作用。对于严重程度较高的患者,条件间接效应为-0.42(95% CI = -0.78,-0.18)(预期平均 BDI-II 降低 = 10 分);对于严重程度较低(预期平均 BDI-II 降低 = 3.5 分)的患者,条件间接效应为-0.15(95% CI = -0.35,-0.02)。抑郁症严重程度较高的人可能会从 MBCT 对残余症状的支持中获益最多。目前还不清楚这些效果是否适用于当前抑郁发作的患者。未来的研究应该对未接受药物治疗的人进行调查。本研究为复发性抑郁症的个性化管理提供了初步证据。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Examining what works for whom and how in mindfulness-based cognitive therapy (MBCT) for recurrent depression: moderated-mediation analysis in the PREVENT trial
Background

Personalised management of recurrent depression, considering individual patient characteristics, is crucial.

Aims

This study evaluates the potentially different mediating role of mindfulness skills in managing recurrent depression using mindfulness-based cognitive therapy (MBCT) among people with varying depression severity.

Method

Data from the Prevention of Depressive Relapse or Recurrence (PREVENT) trial, comparing MBCT (with antidepressant medication (ADM) tapering support, MBCT-tapering support) versus maintenance-ADM, were used. The study included pre, post, 9-, 12-, 18- and 24-month follow-ups. Adults with ≥3 previous major depressive episodes, in full/partial remission (below threshold for a current episode), on ADM, were assessed for eligibility in primary care practices in the UK. People were randomised (1:1) to MBCT-tapering support or maintenance-ADM. We used the Beck Depression Inventory-II to evaluate depressive symptom changes over the six time points. Pre-post treatment, we employed the Five Facets of Mindfulness Questionnaire to gauge mindfulness skills. Baseline symptom and history variables were used to identify individuals with varying severity profiles. We conducted Latent Profile Moderated-Mediation Growth Mixture Models.

Results

A total of 424 people (mean (s.d.) age = 49.44 (12.31) years; with 325 (76.7%) self-identified as female) were included. A mediating effect of mindfulness skills, between trial arm allocation and the linear rate of depressive symptoms change over 24 months, moderated by depression severity, was observed (moderated-mediation index = −0.27, 95% CI = −0.66, −0.03). Conditional indirect effects were −0.42 (95% CI = −0.78, −0.18) for higher severity (expected mean BDI-II reduction = 10 points), and −0.15 (95% CI = −0.35, −0.02) for lower severity (expected mean BDI-II reduction = 3.5 points).

Conclusions

Mindfulness skills constitute a unique mechanism driving change in MBCT (versus maintenance-ADM). Individuals with higher depression severity may benefit most from MBCT-tapering support for residual symptoms. It is unclear if these effects apply to those with a current depressive episode. Future research should investigate individuals who are not on medication. This study provides preliminary evidence for personalised management of recurrent depression.

Trial Registration:

ISRCTN26666654.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信